We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Periodically perform skin examinations in patients on bendamustine-containing regimens and consider PML in the differential diagnosis for patients on bendamustine with new or worsening neurological, cognitive, or behavioural signs or symptoms.
Ground-breaking new cancer treatments have moved a step closer with the signing of a major agreement between the government and BioNTech SE.
First published during the 2022 to 2024 Sunak Conservative government
Pioneering treatment for multiple myeloma - partially-funded by an Innovate UK grant - reaches clinical stage.
Three in every four people survive their cancer the first year after being diagnosed, with rates of survival for some cancers even higher, according to latest figures.
The Government Office for Technology Transfer (GOTT) has funded the National Physical Laboratory’s development of new ultrasound technology in breast cancer diagnosis.
New cancer trials to begin using personalised treatment to save lives.
The third-line treatment indication for rucaparib has been withdrawn following a review of the findings of the ARIEL-4 trial, which showed lower overall survival for rucaparib treatment versus standard chemotherapy in patients with high-grade epithelial ovarian, fallopian tube or primary...
Health Secretary Sajid Javid's speech at the Francis Crick Institute on World Cancer Day.
First published during the 2019 to 2022 Johnson Conservative government
Fatal cases of tumour lysis syndrome (TLS) have been reported, some occurring in patients with chronic lymphocytic leukaemia receiving the lowest venetoclax dose used in the dose-titration schedule. For all patients, it is important to strictly adhere to the dose-titration...
Turing AI Acceleration Fellowships will give 15 of the UK’s top AI innovators the resources to drive forward their ground-breaking research.
Employment Appeal Tribunal judgment of Judge Auerbach on 15 July 2021.
Nine of the most promising artificial intelligence healthcare technologies to receive nearly £16 million in government funding to accelerate research.
Tofacitinib should not be used in patients older than 65 years of age, people who are current or past smokers, or individuals with other cardiovascular (such as diabetes or coronary artery disease) or malignancy risk factors unless there are no...
Call for evidence to inform an ambitious 10-Year Cancer Plan extended to Friday 8 April to ensure everyone has their say.
Cancer therapies research funding will support clinical trials of new T-cell treatment.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Thirty-eight new pioneering artificial intelligence (AI) projects announced to help revolutionise care and accelerate diagnosis.
The regulator has opened a statutory inquiry into patient support and cancer awareness charity Melanoma UK -- Incorporating Factor 50.
Updated safety recommendations have been issued as part of the European review evaluating cases of neural tube defects in babies born to mothers who became pregnant while taking the HIV medicine dolutegravir. Evidence collected as more women have given birth...
Employment Tribunal decision.
Patients with complete or partial dihydropyrimidine dehydrogenase (DPD) deficiency are at increased risk of severe and fatal toxicity during treatment with these medicines. All patients should be tested for DPD deficiency before initiation to minimise the risk of these reactions....
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).